Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Opdivo · 4.8 · Nivolumab in combination with cabozantinib“
Suchtreffer
Begriffe & Kennungen
Opdivo · 4.8 · 29 chemotherapy (n = 1800), and nivolumab in combination with cabozantinib (n = 320) are presented in Table 19
Eintrag öffnenOpdivo · 4.8 · For patients treated with nivolumab in combination with cabozantinib, data from RCC patients 75 years of age o
Eintrag öffnenOpdivo · 4.8 · For patients treated with nivolumab in combination with cabozantinib, data from RCC patients 75 years of age o
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of diarrhoea, colitis, freq
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of diarrhoea, colitis, freq
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of hypersensitivity/infusio
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of hypersensitivity/infusio
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of liver function test abno
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of liver function test abno
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of nephritis, immune mediat
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of nephritis, immune mediat
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of pneumonitis including in
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of pneumonitis including in
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of rash was 62.8% (201/320)
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of rash was 62.8% (201/320)
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of thyroid disorders was 43
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of thyroid disorders was 43
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the proportion of patients who experience
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the proportion of patients who experience
Eintrag öffnenOpdivo · 4.8 · In the dataset of nivolumab 240 mg every 2 weeks in combination with cabozantinib 40 mg once daily in RCC (n =
Eintrag öffnen